CSL simplifies pay disclosure to avert 'second strike'

Blood products giant CSL has simplified the way it structures executive pay and added a novel "take-home pay" table to its annual report in an attempt to head off a "second strike" against chief executive Paul Perreault's remuneration.

Mr Perreault was paid $US8.18 million ($10.25 million) in the year to June 30, including $US4.2 million in cash salary and bonuses and just under $US4 million in long-term and share-based incentives, about the same as in 2016.